Overview
Papillary fibroelastoma (PFE) of the heart is a rare, benign primary cardiac tumor. This Orphanet entry (208600) is classified as OBSOLETE, meaning it has been retired or reclassified within the Orphanet nomenclature, potentially merged with a broader category of cardiac tumors. Papillary fibroelastomas are the most common valvular tumors of the heart and the second most common benign cardiac tumor after myxomas. They are small, avascular, papilloma-like growths typically found on cardiac valve surfaces, most frequently the aortic valve, though they can occur on any valve or endocardial surface. Papillary fibroelastomas primarily affect the cardiovascular system. Many patients are asymptomatic, with the tumor discovered incidentally during echocardiography or cardiac surgery. However, PFEs can cause serious complications including stroke, transient ischemic attacks, peripheral embolization, and, rarely, sudden cardiac death due to coronary artery embolism. Symptoms, when present, are typically related to thromboembolic events rather than the tumor itself. The tumors are composed of avascular papillary fronds of dense connective tissue covered by endothelium, with an elastic fiber core. Treatment for symptomatic papillary fibroelastomas or those at high risk for embolization is surgical excision, which is generally curative with excellent long-term outcomes. Valve-sparing surgical techniques are preferred when possible. For asymptomatic patients with small, non-mobile tumors, conservative management with close echocardiographic surveillance may be appropriate. The etiology of PFE remains uncertain, with theories including hamartomatous origin, organized thrombus, or response to endocardial damage. These tumors are most commonly diagnosed in adults, typically in the fifth to seventh decades of life.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Papillary fibroelastoma of the heart.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Papillary fibroelastoma of the heart at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Papillary fibroelastoma of the heart.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Papillary fibroelastoma of the heart.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Papillary fibroelastoma of the heart.
Start the conversation →Latest news about OBSOLETE: Papillary fibroelastoma of the heart
No recent news articles for OBSOLETE: Papillary fibroelastoma of the heart.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Papillary fibroelastoma of the heart
What is OBSOLETE: Papillary fibroelastoma of the heart?
Papillary fibroelastoma (PFE) of the heart is a rare, benign primary cardiac tumor. This Orphanet entry (208600) is classified as OBSOLETE, meaning it has been retired or reclassified within the Orphanet nomenclature, potentially merged with a broader category of cardiac tumors. Papillary fibroelastomas are the most common valvular tumors of the heart and the second most common benign cardiac tumor after myxomas. They are small, avascular, papilloma-like growths typically found on cardiac valve surfaces, most frequently the aortic valve, though they can occur on any valve or endocardial surfac
How is OBSOLETE: Papillary fibroelastoma of the heart inherited?
OBSOLETE: Papillary fibroelastoma of the heart follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Papillary fibroelastoma of the heart typically begin?
Typical onset of OBSOLETE: Papillary fibroelastoma of the heart is adult. Age of onset can vary across affected individuals.